Blue Jet Healthcare Limited
Book Built Issue IPO · NSE, BSE
- Price band
- ₹329 - ₹346
- Lot size
- 43 shares
- Issue amount
- ₹840.27 cr
- Total subscription
- 7.94×
- Opens
- 25 Oct 2023
- Closes
- 27 Oct 2023
- Allotment
- 30 Oct 2023
- Listing
- 1 Nov 2023
Offer at a glance
Issue overview
- Issue size
- 2,42,85,160 shares
- Face value
- ₹2 per share
- Minimum investment
- ₹14,147
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹840.27 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,878
- Issue type
- Book Built Issue IPO
- Shares before issue
- 17,34,65,425
- Shares after issue
- 17,34,65,425
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 43 | ₹14,878 |
| sHNI | 14 | 602 | ₹2,08,292 |
| bHNI | 68 | 2,924 | ₹10,11,704 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| — | — |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 168.05 | 2,306.13 |
| RETAIL | 294.09 | 653.79 |
| NIB | 126.04 | 1,712.69 |
| HNIs 2+ | 42.01 | 397.61 |
| HNIs 10+ | 84.03 | 1,315.08 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Values |
|---|---|
| EPS | 9.23 |
| ROE | 26.6 |
| ROCE | 31.91 |
| RONW | 23.48 |
| PRE IPO(PE) | 37.49 |
| POST IPO(PE) | 34.02 |
Values and labels as reported in the issue data.
Company information
Company profile
Incorporated in 1968, Blue Jet Healthcare is a science-led pharmaceutical company specializing in healthcare ingredients and intermediates. The company was the first in India to manufacture saccharin and its salts and has since expanded into contrast media intermediates for CT scans and MRIs. Its main product categories include contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and APIs. Blue Jet Healthcare offers process development, production capabilities, global regulatory support, and collaboration in advanced pharmaceutical development. The company operates three manufacturing facilities in Shahad, Ambernath, and Mahad, Maharashtra, with annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively, as of June 30, 2023.
Strengths
- One of the largest manufacturing capacities for contrast media intermediates in India.
- Operates in a niche segment with high entry barriers — limited competition and strong pricing power.
- Strong and long-term relationships, supported by long-duration contracts with leading multinational customers.
Promoters
Akshay Bansarilal Arora
Shiven Akshay Arora
Archana & Akshay Arora
Registrar & documents
Lead manager
Kotak Mahindra Capital Company Limited, ICICI Securities Limited, J.P. Morgan India Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
701, 702, 7th Floor, Bhumiraj Costarica Sector 18, Sanpada Navi Mumbai, Thane – 400 705
+91 (22) 4184 0550
[email protected]Company website ↗Understanding BLUEJET IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.